Advancing translational research for colorectal immuno-oncology

Colorectal cancer (CRC) is a common and deadly disease. Unfortunately, immune checkpoint inhibitors (ICIs) fail to elicit effective anti-tumour responses in the vast majority of CRC patients. Patients that are most likely to respond are those with DNA mismatch repair deficient (dMMR) and microsatell...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Elaine M., Wright, Josephine A., Blake, Stephen J., Page, Amanda J., Worthley, Daniel L., Woods, Susan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628092/
https://www.ncbi.nlm.nih.gov/pubmed/37563222
http://dx.doi.org/10.1038/s41416-023-02392-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628092/
https://www.ncbi.nlm.nih.gov/pubmed/37563222
http://dx.doi.org/10.1038/s41416-023-02392-x

Ejemplares similares